At the terminal time-point analysis, when the treated tumor growth started to escape, we did not observe any changes in the T and NK cell infiltration in the huCC49-IL-2-treated tumors compared to the untreated controls (Figure 3B). The gene discussed is IL2; the disease is neoplasm.